Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rgmxen.2020.04.001 http://scihub22266oqcxt.onion/10.1016/j.rgmxen.2020.04.001 C7180357!7180357!C7180357     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ä-/-ä 2020 ; 85 (3): 282-7 Nephropedia Template TP {{tp|p=C7180357|t=2020. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19? |pdf=|usr=}}{{C7180357}} gab.com Text Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 JO: ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7180357 #FOAvip Background: There is a growing number of reports of COVID-19 cases presenting gastrointestinal (GI) symptoms. Aims: To review studies reporting GI symptoms among COVID-19 patients. Results: Fifteen papers (2800 patients) were identified. Frequency of GI symptoms varied from 3.0% to 39.6%, including diarrhea: 7.5%, nausea: 4.5%, anorexia: 4.4%, vomiting: 1.3%, abdominal pain: 0.5%, belching/reflux: 0.3%. These may be the first manifestation of COVID-19, however, there is controversy whether these reflect better or worst prognosis. Finally, the potential relationship with the angiotensin converting enzyme 2 (ACE2) cell receptor in the digestive tract as the virus entry route, is discussed. Conclusions: GI symptoms may be common in COVID-19 and may be the first manifestation before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists need to be aware of these atypical cases during the current pandemic and of the fecal?oral transmission, and preventive measures may be implemented. Twit Text FOAVip Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 ????ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7180357 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=C7180357 #FOAvip English Wikipedia <ref>{{Cite pmid|C7180357}}</ref> Beware: Gastrointestinal symptoms can be a manifestation of COVID-19? #MMPMIDC7180357 Schmulson M; Dávalos M; Berumen J ä-/-ä 2020[Jul]; 85 (3): 282-7 PMIDC7180357show ga Background: There is a growing number of reports of COVID-19 cases presenting gastrointestinal (GI) symptoms. Aims: To review studies reporting GI symptoms among COVID-19 patients. Results: Fifteen papers (2800 patients) were identified. Frequency of GI symptoms varied from 3.0% to 39.6%, including diarrhea: 7.5%, nausea: 4.5%, anorexia: 4.4%, vomiting: 1.3%, abdominal pain: 0.5%, belching/reflux: 0.3%. These may be the first manifestation of COVID-19, however, there is controversy whether these reflect better or worst prognosis. Finally, the potential relationship with the angiotensin converting enzyme 2 (ACE2) cell receptor in the digestive tract as the virus entry route, is discussed. Conclusions: GI symptoms may be common in COVID-19 and may be the first manifestation before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists need to be aware of these atypical cases during the current pandemic and of the fecal?oral transmission, and preventive measures may be implemented. äBeware: Gastrointestinal symptoms can be a manifestation of COVID-19? (epmc).pdf DeepDyve Pubget Overpricing